Skip to content
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

Day: 19 September 2022

  1. Home
  2. Archives: September 2022

Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction

The progression and development of congestive heart failure is still considered a large problem despite the existence of revascularization therapies and optimal, state-of-the-art medical services.

Continue reading
biobank Cord blood mesenchymal stem cells Stem cells Swiss stem cells biotech

Recent Posts

  • The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure
  • Umbilical blood stem cell transplant puts woman in HIV remission
  • Stem Cells and Cardiac Disease: Where are We Going?
  • Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants
  • Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases

Recent Comments

No comments to show.
Linkedin
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

©2022 Swiss Stem Cells Biotech SA – P.IVA CH277426754